Prof. Chan SY, Dr. Thomas B from the Divisions of Cardiovascular Medicine and Network Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA, has published a research paper in the 24 June 2014 J Clin Invest. (I.F: >15) stating that “Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension” This study provides mechanistic insights into how miR-130/301 promotes PH pathogenesis.
In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Natural product-based therapy for Hypertension: The neem oil component Oleic acid inhibits pulmonary hypertension via down regulation of its target gene. This study suggests that pharmacological formulations encompassing “Oleic acid or its analogues” can be used in the treatment of pulmonary hypertension.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Natural product-based therapy for Hypertension: The neem oil component Oleic acid inhibits pulmonary hypertension via down regulation of its target gene, 25/June/2014, 5.50 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
* Research cooperation
